Suppression of inducible nitric oxide synthase expression and amelioration of lipopolysaccharide-induced liver injury by polyphenolic compounds in Eucalyptus globulus leaf extract

Food Chemistry

Volumn 125, Issue 2, 2011, Pages 442-446

  Sugimoto, Keiichiro ^a,b   Sakamoto, Sayaka ^a   Nakagawa, Kazuya ^b   Hayashi, Shuichi ^b   Harada, Naoki ^a   Yamaji, Ryoichi ^a   Nakano, Yoshihisa ^a,c   Inui, Hiroshi ^a  

^a Osaka Prefecture University   (Japan)

^b Nagaoka Perfumery Co Ltd   (Japan)

^c Osaka Women's Junior College   (Japan)

Author keywords

Anti inflammation; Ellagic acid; Endotoxin; Eucalyptus globulus; Gallic acid; Hepatoprotective effect; Thiobarbituric acid reactive substance

Indexed keywords

ANTI-INFLAMMATION; ELLAGIC ACID; ENDOTOXIN; EUCALYPTUS GLOBULUS; GALLIC ACIDS; HEPATOPROTECTIVE; THIOBARBITURIC ACID-REACTIVE SUBSTANCES;

AMINO ACIDS; BODY FLUIDS; NITRIC OXIDE; NUTRITION; PATHOLOGY;

LIVER;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ELLAGIC ACID; GALLIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; EUCALYPTUS GLOBULUS; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; PROTEIN EXPRESSION; TREE;

EUCALYPTUS; EUCALYPTUS GLOBULUS; MUS;

EID: 78049443714     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.09.026     Document Type: Article

References (32)

1. Amakura Y., Umino Y., Tsuji S., Ito H., Hatano T., Yoshida T., et al. Constituents and their antioxidative effects in eucalyptus leaf extract used as a natural food additive. Food Chemistry 2002, 77:47-56.
2. Amakura Y., Yoshimura M., Sugimoto N., Yamazaki T., Yoshida T. Marker constituents of the natural antioxidant eucalyptus leaf extract for the evaluation of food additives. Bioscience, Biotechnology, and Biochemistry 2009, 73:1060-1065.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
4. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
5. Caradonna L., Amati L., Magrone T., Pellegrino N.M., Jirillo E., Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. Journal of Endotoxin Research 2000, 6:205-214.
6. Chen Y.C., Shen S.C., Lee W.R., Hou W.C., Yang L.L., Lee T.J. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. Journal of Cellular Biochemistry 2001, 82:537-548.
7. Deitch E.A. Simple intestinal obstruction causes bacterial translocation in man. Archives of Surgery 1989, 124:699-701.
8. Hsieh P.S., Chan J.Y., Shyu J.F., Chen Y.T., Loh C.H. Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic β-cell dysfunction in rats. European Journal of Clinical Investigation 2008, 38:640-648.
9. Inoue, S. (2007). Eucalyptus leaf extract. In Subcommittee on Food Additives, Food Sanitation Committee, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan, Report of the MHLW-Grant-in-Aid Research Project: Hazard-based peer-review studies on the safety surveillance of existing food additives (Kouseiroudoukagakukenkyuu Chousakenkyuuhoukokusho: Kizontenkabutsu No Anzensei No Minaoshi Ni Kansuru Chousakenkyuu) (pp. 14-15). Tokyo: Ministry of Health, Labour and Welfare of Japan.
10. Ishii R., Saito K., Horie M., Shibano T., Kitanaka S., Amano F. Inhibitory effects of hydrolyzable tannins from Melastoma dodecandrum Lour. on nitric oxide production by a murine macrophage-like cell line, RAW264.7, activated with lipopolysaccharide and interferon-γ. Biological & Pharmaceutical Bulletin 1999, 22:647-653.
11. Jorens P.G., Matthys K.E., Bult H. Modulation of nitric oxide synthase activity in macrophages. Mediators of Inflammation 1994, 4:75-89.
12. Julkunen-Tiitto R. Phenolic constituents in the leaves of northern willows: Methods for the analysis of certain phenolics. Journal of Agricultural and Food Chemistry 1985, 33:213-217.
13. Laskin J.D., Heck D.E., Gardner C.R., Laskin D.L. Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxidants & redox signaling 2001, 3:261-271.
14. Lee S.J., Lee I.S., Mar W. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1, 2, 3, 4, 6-penta-O-galloyl-β-d-glucose in murine macrophage cells. Archives of Pharmacal Research 2003, 26:832-839.
15. Lei F., Xing D.M., Xiang L., Zhao Y.N., Wang W., Zhang L.J., et al. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. The Journal of Chromatography B 2003, 796:189-194.
16. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Molecular Pharmacology 1997, 52:465-472.
17. Maes M., Mihaylova I., Leunis J.C. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. Journal of Affective Disorders 2007, 99:237-240.
18. Matsuzaki J., Kuwamura M., Yamaji R., Inui H., Nakano Y. Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. The Journal of Nutrition 2001, 131:2139-2144.
19. McDonald M.C., d'Emmanuele di Villa Bianca R., Wayman N.S., Pinto A., Sharpe M.A., Cuzzocrea S., et al. A superoxide dismutase mimetic with catalase activity (EUK-8) reduces the organ injury in endotoxic shock. European Journal of Pharmacology 2003, 466:181-189.
20. Medvedev A.E., Kopydlowski K.M., Vogel S.N. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. Journal of Immunology 2000, 164:5564-5574.
21. Miele L., Valenza V., La Torre G., Montalto M., Cammarota G., Ricci R., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009, 49:1877-1887.
22. Morrison D.C., Danner R.L., Dinarello C.A., Munford R.S., Natanseon C., Pollack M., et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: Current status and future direction. Journal of Endotoxin Research 1994, 1:71-83.
23. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
24. Peitzman A.B., Udekwu A.O., Ochoa J., Smith S. Bacterial translocation in trauma patients. The Journal of Trauma 1991, 31:1083-1086.
25. Pinsky M.R. Sepsis and multiple organ failure. Contributions to Nephrology 2007, 156:47-63.
26. Purohit V., Bode J.C., Bode C., Brenner D.A., Choudhry M.A., Hamilton F., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: Summary of a symposium. Alcohol 2008, 42:349-361.
27. 6 astrocyte cell culture by various dietary compounds. Proceedings of the Society for Experimental Biology and Medicine 1998, 218:390-397.
28. Sugimoto K., Nakagawa K., Hayashi S., Yoshimura M., Amakura Y., Yoshida T., et al. Hydrolyzable tannins as antioxidants in the leaf extract of Eucalyptus globulus possessing tyrosinase and hyaluronidase inhibitory activities. Food Science and Technology Research 2009, 15:331-336.
29. Sugino K., Dohi K., Yamada K., Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 1987, 101:746-752.
30. Sugita H., Kaneki M., Tokunaga E., Sugita M., Koike C., Yasuhara S., et al. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. American Journal of Physiology. Endocrinology and Metabolism 2002, 282:E386-E394.
31. Vigo E., Cepeda A., Gualillo O., Perez-Fernandez R. In-vitro anti-inflammatory effect of Eucalyptus globulus and Thymus vulgaris: Nitric oxide inhibition in J774A.1 murine macrophages. The Journal of Pharmacy and Pharmacology 2004, 56:257-263.
32. Zong L., Inoue M., Nose M., Kojima K., Sakaguchi N., Isuzugawa K., et al. Metabolic fate of gallic acid orally administered to rats. Biological & Pharmaceutical Bulletin 1999, 22:326-329.